Similar articles for PMID: 14977595

Year	Number of Results
1998	2
2001	1
2003	1
2004	4
2005	6
2007	2
2008	2
2011	2
2012	2
2013	4
2014	8
2015	9
2016	11
2017	4
2018	6
2019	2
2021	3
2024	0

1

Alterations of cell signaling pathways in pancreatic cancer.

Freeman JW, DeArmond D, Lake M, Huang W, Venkatasubbarao K, Zhao S. Freeman JW, et al. Front Biosci. 2004 May 1;9:1889-98. doi: 10.2741/1388. Front Biosci. 2004. PMID: 14977595 Review.

2

Signaling pathways in pancreatic cancer.

Preis M, Korc M. Preis M, et al. Crit Rev Eukaryot Gene Expr. 2011;21(2):115-29. doi: 10.1615/critreveukargeneexpr.v21.i2.20. Crit Rev Eukaryot Gene Expr. 2011. PMID: 22077151 Review.

3

Pancreatic Adenocarcinoma Therapeutics Targeting RTK and TGF Beta Receptor.

Yang HH, Liu JW, Lee JH, Harn HJ, Chiou TW. Yang HH, et al. Int J Mol Sci. 2021 Jul 29;22(15):8125. doi: 10.3390/ijms22158125. Int J Mol Sci. 2021. PMID: 34360896 Free PMC article. Review.

4

The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.

García-Reyes B, Kretz AL, Ruff JP, von Karstedt S, Hillenbrand A, Knippschild U, Henne-Bruns D, Lemke J. García-Reyes B, et al. Int J Mol Sci. 2018 Oct 18;19(10):3219. doi: 10.3390/ijms19103219. Int J Mol Sci. 2018. PMID: 30340359 Free PMC article. Review.

5

Signal transduction in human pancreatic cancer: roles of transforming growth factor beta, somatostatin receptors, and other signal intermediates.

Li M, Becnel LS, Li W, Fisher WE, Chen C, Yao Q. Li M, et al. Arch Immunol Ther Exp (Warsz). 2005 Sep-Oct;53(5):381-7. Arch Immunol Ther Exp (Warsz). 2005. PMID: 16314822 Review.

6

TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.

Alvarez MA, Freitas JP, Mazher Hussain S, Glazer ES. Alvarez MA, et al. J Gastrointest Cancer. 2019 Jun;50(2):207-213. doi: 10.1007/s12029-018-00195-5. J Gastrointest Cancer. 2019. PMID: 30891677 Review.

7

Microenvironmental factors and extracellular matrix degradation in pancreatic cancer.

Binker MG, Binker-Cosen MJ, Binker-Cosen AA, Cosen-Binker LI. Binker MG, et al. JOP. 2014 Jul 28;15(4):280-5. doi: 10.6092/1590-8577/2638. JOP. 2014. PMID: 25076320 Free article. Review.

8

The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.

Fu Y, Liu S, Zeng S, Shen H. Fu Y, et al. Mol Cancer. 2018 Feb 19;17(1):62. doi: 10.1186/s12943-018-0815-z. Mol Cancer. 2018. PMID: 29458370 Free PMC article. Review.

9

VAV1: a new target in pancreatic cancer?

Denicola G, Tuveson DA. Denicola G, et al. Cancer Biol Ther. 2005 May;4(5):509-11. doi: 10.4161/cbt.4.5.1781. Epub 2005 May 2. Cancer Biol Ther. 2005. PMID: 15970675 Review.

10

TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.

Thakur AK, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, Bartholin L, Chan P, Calvo E, Iovanna JL, Vasseur S, Guillaumond F, Tomasini R. Thakur AK, et al. Cell Death Differ. 2016 Aug;23(8):1358-70. doi: 10.1038/cdd.2016.18. Epub 2016 Mar 4. Cell Death Differ. 2016. PMID: 26943320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

63 results

Results by year